Tag: Blockmir CD5-2
Researchers discover novel drug that shows potential in treating advanced liver cancer
Researchers at the Centenary Institute have identified a potential breakthrough in the treatment of hepatocellular carcinoma (HCC), the most prevalent form of liver cancer and the third leading cause of cancer-related deaths worldwide.
Featured Article
Reality check: Aussie factories’ journey to responsible AI implementation
Artificial intelligence has become more than just a buzzword as it promises to revolutionise every other industry in the world, including manufacturing. In Australia, in particular, the hype surrounding AI and automation has reached a fever pitch, with many business leaders leveraging their resources to race towards adoption and implementation.
